Home   About Us   Services   Industries   Solutions   Clients   Resources   Locations   Contact Us   Free Quotes
   
 
 
 
 
 
 
 
 
 
History
Leadership
Network
Press Center
Our Quality
Technology
Experience
Partners
Corporate Citizenship
Awards
Careers
 
 
 
 
 

Case Study:
GENENTECH AND NOVARTIS

Helping Achieve FDA Approval Through Superior Translations

Genentech and Novartis had invested millions of dollars into the development of Xolair. However, in order to submit the treatment to the FDA for approval, over 1,000 pages of documentation would need to be translated from French to English.

Click here to read more about this case study.